Literature DB >> 4524178

[Metronidazole-spiramycin combination. In situ concentrations and synergism compared with the minimal inhibitory concentration of the buccal flora].

J Laufer, H Mignon, D Videau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4524178

Source DB:  PubMed          Journal:  Rev Stomatol Chir Maxillofac        ISSN： 0035-1768


× No keyword cloud information.
  7 in total

Review 1.  Bacterial synergy in pelvic inflammatory disease.

Authors:  I Brook
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

Review 2.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

3.  In vitro activity of rodogyl against putative periodontopathic bacteria.

Authors:  T C Quee; T Roussou; E C Chan
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

4.  Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.

Authors:  I Brook; J C Coolbaugh; R I Walker; E Weiss
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

Review 6.  Antimicrobial drugs used in the management of anaerobic infections in children.

Authors:  I Brook
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

Review 7.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.